Item selection for the development and validation of a revised classification criteria for adult and juvenile idiopathic inflammatory myopathies: MyoROC project
The new items that will be tested in the revised criteria were generated with input from a wide range of stakeholders and included, most importantly, MSA, pattern of weakness, skin changes, and additional diagnostic modalities. The next steps of the project are data collection followed by statistical analysis for development and validation of the revised criteria.
Authors
- Manabu Fujimoto (ORCID: https://orcid.org/0000-0002-3062-4872)
- Didem Saygın
- Ingrid E. Lundberg (ORCID: https://orcid.org/0000-0002-6068-9212)
- Lorenzo Cavagna (ORCID: https://orcid.org/0000-0003-3292-1528)
- Clarissa Pilkington (ORCID: https://orcid.org/0000-0003-2289-2428)
- Rohit Aggarwal (ORCID: https://orcid.org/0000-0001-7531-8038)
- Victoria P. Werth (ORCID: https://orcid.org/0000-0003-3030-5369)
- Guochun Wang (ORCID: https://orcid.org/0000-0002-4616-9376)
- Samuel Katsuyuki Shinjo (ORCID: https://orcid.org/0000-0002-3682-4517)
- Mohammed Tikly (ORCID: https://orcid.org/0000-0001-7850-3538)
- Lisa G. Rider (ORCID: https://orcid.org/0000-0002-6912-2458)
- Rachel Zeng
- Jasvinder A. Singh (ORCID: https://orcid.org/0000-0003-3485-0006)
- Mazen M. Dimachkie (ORCID: https://orcid.org/0000-0002-7148-989X)
- Merrilee Needham (ORCID: https://orcid.org/0000-0001-6591-1444)
- Matteo Bottai (ORCID: https://orcid.org/0000-0002-3531-2739)
- Stefanie Glaubitz
- Liza Rajasekhar (ORCID: https://orcid.org/0000-0002-9789-9985)
- Marjolein Visser (ORCID: https://orcid.org/0000-0002-5136-298X)
- Sonye K. Danoff (ORCID: https://orcid.org/0000-0001-9172-8977)
- Masataka Kuwana (ORCID: https://orcid.org/0000-0001-8352-6136)
- Pedro Machado (ORCID: https://orcid.org/0000-0002-8411-7972)
- Yasser Salem (ORCID: https://orcid.org/0000-0001-8951-3109)
- Anthony A. Amato (ORCID: https://orcid.org/0009-0006-3884-6644)
Institutions
- Brigham and Women's Hospital (US)
- Rush University Medical Center (US)
- National Institutes of Health (US)
- Michael E. DeBakey VA Medical Center (US)
- Karolinska University Hospital (SE)
- University College London Hospitals NHS Foundation Trust (GB)
- Harvard University (US)
- Hofstra University (US)
- Nizam's Institute of Medical Sciences (IN)
- Johns Hopkins University (US)
- University of Pittsburgh (US)
- Universidade de São Paulo (BR)
- University of the Witwatersrand (ZA)
- University of Pavia (IT)
- Johns Hopkins Medicine (US)
- Great Ormond Street Hospital (GB)
- Fiona Stanley Hospital (AU)
- China-Japan Friendship Hospital (CN)
- Karolinska Institutet (SE)
- National Institute of Environmental Health Sciences (US)
- Amsterdam Neuroscience (NL)
- Universitätsmedizin Göttingen (DE)
- University of Kansas Medical Center (US)
- Policlinico San Matteo Fondazione (IT)
- University Hospital Carl Gustav Carus (DE)
- University College London (GB)
- University of Pennsylvania (US)
- Nippon Medical School (JP)
- University of Amsterdam (NL)
- The University of Osaka (JP)
Publication Details
- Journal
- Seminars in Arthritis and Rheumatism
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1016/j.semarthrit.2025.152822
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Yale University
- Gilead Sciences
- Biogen
- Rheumatology Research Foundation
- Alexion Pharmaceuticals
- Medpace
- United Therapeutics Corporation
- CSL Behring
- Amarin Corporation
- Horizon Pharmaceuticals
- Amicus Therapeutics
- Kiniksa Pharmaceuticals
- BeiGene
- Cure JM Foundation
- Argenx
- Moderna
- Seres Therapeutics
- Horizon Therapeutics
- Grifols
- National Institutes of Health
- EMD Serono
- Chugai Pharmaceutical
- National Institute of Environmental Health Sciences